创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

ZHENG Yadan, KANG Ziyao, WANG Chun, LIU Yang. Advances in Nanomedicines for Brain Tumor Treatments[J]. Progress in Pharmaceutical Sciences, 2021, 45(12): 905-918.
Citation: ZHENG Yadan, KANG Ziyao, WANG Chun, LIU Yang. Advances in Nanomedicines for Brain Tumor Treatments[J]. Progress in Pharmaceutical Sciences, 2021, 45(12): 905-918.

Advances in Nanomedicines for Brain Tumor Treatments

  • Malignant brain tumors seriously threaten human health.Despite the great progress in medical treatment with better clinical technology, the prognosis for most brain cancer patients still remains poor.The protective blood brain barrier (BBB) blocks the effective delivery of drugs, leading to the treatment failure of various drugs.Recent breakthroughs in nanotechnology have endowed multifunctional nanomedicines with the ability to cross the BBB, enabling accumulation of therapeutic drugs in brain tumors.This review discusses the design strategies of BBB-crossing nanomedicines and their current progress in brain tumor treatment, and summarizes the existing problems of nanomedicines for brain tumor treatment as well as the potential strategies to overcome these limitations, so as to provide reference for developing nanomedicines for brain tumor treatment.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return